The Centrum Medycyny Konopnej (CMK) group, a leader in Poland's medical services market utilizing medical marijuana therapy, plans to introduce hemp products to pharmacies in 2024 through a partnership with the German pharmaceutical giant, Sanity Group.
After registration, CMK will be the sole entity in Poland with such a diverse portfolio of medical marijuana products. The move aims to address the increasing demand for therapeutic cannabis and the limited availability of products in Poland. CMK conducted market research and audits to tailor its product offerings to meet patient needs. Their goal is to enhance treatment options and improve patient outcomes, contributing to the growth of the medical marijuana industry.
Source: strefainwestorow.pl